Medicare Enrolled
Dr. Jacqueline Barrientos, M.D.
Hematology & Oncology · Miami Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barrientos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barrientos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barrientos
Dr. Jacqueline Barrientos is a hematology & oncology specialist in Miami Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Barrientos performed 659 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Barrientos received a total of $179,531 from 64 pharmaceutical and/or device companies across 454 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barrientos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 659 Medicare services
$179,531 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 154737 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗659
Medicare services
Bottom 47% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
353 | $82 | $252 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $115 | $356 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $102 | $329 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $87 | $433 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $53 | $165 |
| New patient office visit, complex (60-74 min) | 28 | $131 | $552 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $68 | $228 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $108 | $449 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $149 | $652 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
11 | $61 | $262 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$179,531
Total received (2018-2024)
Avg $25,647/year across 7 years
Top 6% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
454
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,728
2023
$43,966
2022
$18,502
2021
$21,540
2020
$22,083
2019
$18,166
2018
$46,546
Payments by company (2024)
BeiGene USA, Inc.
$3,823
ABBVIE INC.
$2,145
Celgene Corporation
$640
Daiichi Sankyo Inc.
$248
Merck Sharp & Dohme LLC
$177
PFIZER INC.
$174
Genentech USA, Inc.
$138
Janssen Biotech, Inc.
$131
Novartis Pharmaceuticals Corporation
$112
Rigel Pharmaceuticals, Inc.
$107
Takeda Pharmaceuticals U.S.A., Inc.
$96
AstraZeneca Pharmaceuticals LP
$96
Astellas Pharma US Inc
$82
Incyte Corporation
$61
SOBI, INC
$58
Eisai Inc.
$55
Adaptive Biotechnologies Corporation
$53
GENZYME CORPORATION
$51
Genmab U.S., Inc.
$46
SpringWorks Therapeutics, Inc.
$42
TAIHO ONCOLOGY, INC.
$40
Lilly USA, LLC
$40
GlaxoSmithKline, LLC.
$40
Bayer Healthcare Pharmaceuticals Inc.
$36
Pharmacosmos Therapeutics Inc.
$34
Kite Pharma, Inc.
$28
Aveo Pharmaceuticals, Inc.
$24
Agios Pharmaceuticals, Inc.
$23
ARRAY BIOPHARMA INC
$23
EMD Serono, Inc.
$20
Myriad Genetic Laboratories, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
E.R. Squibb & Sons, L.L.C.
$19
Stemline Therapeutics Inc.
$16
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 75.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$50,370
BeiGene USA, Inc.
$26,484
Genentech, Inc.
$18,101
Gilead Sciences, Inc.
$11,281
Janssen Biotech, Inc.
$7,981
Pharmacyclics LLC, An AbbVie Company
$7,438
E.R. Squibb & Sons, L.L.C.
$6,792
AbbVie Inc.
$6,084
Sandoz Inc.
$5,884
Kite Pharma, Inc.
$5,729
Janssen Global Services, LLC
$4,335
Lilly USA, LLC
$4,124
Celgene Corporation
$3,326
Genentech USA, Inc.
$2,387
ABBVIE INC.
$2,167
Merck Sharp & Dohme LLC
$2,115
Bayer HealthCare Pharmaceuticals Inc.
$2,078
TG Therapeutics, Inc.
$2,025
Pharmacyclics LLC, an AbbVie Company
$2,025
Verastem, Inc.
$1,958
AstraZeneca UK Limited
$1,370
Amgen Inc.
$852
Janssen Research & Development, LLC
$749
Janssen Scientific Affairs, LLC
$505
Daiichi Sankyo Inc.
$422
PFIZER INC.
$275
Novartis Pharmaceuticals Corporation
$227
Incyte Corporation
$224
GENZYME CORPORATION
$208
Takeda Pharmaceuticals U.S.A., Inc.
$158
Rigel Pharmaceuticals, Inc.
$120
TG THERAPEUTICS, INC.
$120
Eisai Inc.
$105
GlaxoSmithKline, LLC.
$105
SOBI, INC
$94
Genmab U.S., Inc.
$91
AbbVie, Inc.
$90
Seagen Inc.
$89
Adaptive Biotechnologies Corporation
$88
TAIHO ONCOLOGY, INC.
$82
Astellas Pharma US Inc
$82
Pharmacosmos Therapeutics Inc.
$76
MorphoSys, US Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Myriad Genetic Laboratories, Inc.
$50
SpringWorks Therapeutics, Inc.
$42
Janssen Pharmaceuticals, Inc
$42
Stemline Therapeutics Inc.
$42
ADC Therapeutics America, Inc.
$39
Karyopharm Therapeutics Inc.
$38
SERVIER PHARMACEUTICALS LLC
$37
Bayer Healthcare Pharmaceuticals Inc.
$36
AVEO Pharmaceuticals, Inc.
$32
ImmunoGen, Inc.
$25
Aveo Pharmaceuticals, Inc.
$24
Epizyme, Inc.,
$24
Agios Pharmaceuticals, Inc.
$23
ARRAY BIOPHARMA INC
$23
Deciphera Pharmaceuticals Inc.
$21
EMD Serono, Inc.
$20
Blueprint Medicines Corporation
$19
G1 Therapeutics, Inc.
$18
Foundation Medicine, Inc.
$17
EISAI INC.
$17
Top 3 companies account for 52.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · BLENREP · BOSULIF · BRUKINSA · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELREXFIO · ELZONRIS · EPKINLY · Elahere · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE LIQUID CDX · FRUZAQLA · GAZYVA · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JARDIANCE · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LONSURF · LUMOXITI · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Non-Covered Product · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · Orserdu · PADCEV · PIQRAY · PLUVICTO · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · Rituxan · SARCLISA · Stivarga · TAGRISSO · TAZVERIK · TECVAYLI · TUKYSA · Tibsovo · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XARELTO · XPOVIO · Xospata · Yescarta · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
181
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barrientos is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barrientos experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Barrientos performed 353 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Barrientos receive payments from pharmaceutical companies?
Yes. Dr. Barrientos received a total of $179,531 from 64 companies across 454 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barrientos's costs compare to other hematology & oncology specialists in Miami Beach?
Dr. Barrientos's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barrientos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Miami Beach
Browse hematology & oncology specialists in Miami Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Genentech, Inc. Payments to Doctors
See all physicians who received payments from Genentech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology